ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 254 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,286,613 | -11.5% | 47,884 | +17.4% | 0.00% | -33.3% |
| Q2 2023 | $1,453,901 | +39.2% | 40,784 | -0.8% | 0.00% | +50.0% |
| Q1 2023 | $1,044,385 | -39.7% | 41,117 | -3.8% | 0.00% | -50.0% |
| Q4 2022 | $1,733,362 | +406.8% | 42,722 | +313.2% | 0.00% | +300.0% |
| Q3 2022 | $342,000 | -7.1% | 10,340 | -0.9% | 0.00% | 0.0% |
| Q2 2022 | $368,000 | -76.1% | 10,432 | -3.3% | 0.00% | -66.7% |
| Q1 2022 | $1,538,000 | +10.0% | 10,791 | -48.8% | 0.00% | 0.0% |
| Q4 2021 | $1,398,000 | -8.9% | 21,069 | -14.3% | 0.00% | 0.0% |
| Q3 2021 | $1,534,000 | -44.0% | 24,574 | -25.7% | 0.00% | -50.0% |
| Q2 2021 | $2,739,000 | +138.0% | 33,068 | +90.6% | 0.01% | +100.0% |
| Q1 2021 | $1,151,000 | +20.1% | 17,351 | +39.1% | 0.00% | 0.0% |
| Q4 2020 | $958,000 | +3.8% | 12,475 | -41.8% | 0.00% | 0.0% |
| Q3 2020 | $923,000 | +7.3% | 21,443 | +7.7% | 0.00% | 0.0% |
| Q2 2020 | $860,000 | +123.4% | 19,915 | +48.7% | 0.00% | +50.0% |
| Q1 2020 | $385,000 | – | 13,393 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,264 | $54,392,000 | 33.22% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $216,228,000 | 28.00% |
| L1 Capital Pty Ltd | 296,024 | $19,629,000 | 4.93% |
| Aquilo Capital Management, LLC | 407,926 | $27,050,000 | 4.89% |
| Evolutionary Tree Capital Management, LLC | 72,948 | $4,837,000 | 2.86% |
| ACUTA CAPITAL PARTNERS, LLC | 108,000 | $7,161,000 | 2.58% |
| First Light Asset Management, LLC | 536,836 | $35,598,000 | 2.36% |
| Parkman Healthcare Partners LLC | 70,089 | $4,648,000 | 1.08% |
| Hood River Capital Management LLC | 357,082 | $23,678,000 | 0.76% |
| Vanguard Capital Wealth Advisors | 11,099 | $703,565,000 | 0.60% |